Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have earned an average recommendation of “Hold” from the three analysts that are presently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation. The average 1 year price target among brokers that have updated their coverage on the […]
Shares of Nerdy, Inc. (NYSE:NRDY – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average […]
Shares of Manulife Financial Co. (NYSE:MFC – Get Free Report) (TSE:MFC) have earned a consensus rating of “Buy” from the six analysts that are currently covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have updated their coverage on […]
China Renaissance started coverage on shares of SharkNinja (NYSE:SN – Free Report) in a report published on Wednesday morning, MarketBeat Ratings reports. The brokerage issued a buy rating on the stock. SN has been the subject of several other reports. JPMorgan Chase & Co. started coverage on SharkNinja in a report on Thursday, April 4th. […]
Wedbush cut shares of Ikena Oncology (NASDAQ:IKNA – Free Report) from an outperform rating to a neutral rating in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm currently has $2.00 price target on the stock, down from their prior price target of $8.00. Wedbush also issued estimates for Ikena Oncology’s […]